【レポートの概要（一部）】
1. Report Overview
1.1 World IBD Drugs Market: Overview of Findings
1.2 Why You Should Read This Report
1.3 How That Study Delivers Value
1.4 Main Questions Covered in That Analysis
1.5 Who is the Investigation For?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQ)
1.8 Some Associated Titles
1.9 About Visiongain
2. Introduction to the Inflammatory Bowel Disease Market
2.1 What is Inflammatory Bowel Disease (IBD)?
2.2 Classification of IBD
2.3 Symptoms and Diagnosis of IBD
2.4 Multifactorial Causes of IBD
2.5 How Common is IBD?
2.6 What Are the Treatment Options for IBD?
2.6.1 Aminosalicylates – The Most Common Therapy
2.6.2 Antibiotics – Will There Be Any Supporting Evidence Soon?
2.6.3 Corticosteroids – Uptake from Uceris?
2.6.4 Immunomodulators – Slow to Act?
2.6.5 Monoclonal Antibodies – Not Cost-effective?
2.7 Treatment Goals for IBD – Treat-to-Target Approach?
2.8 Treatment Algorithm – is Top-Down Approach the Future Direction?
3. The World Inflammatory Bowel Disease Market, 2014-2025
3.1 The Inflammatory Bowel Disease Market in 2013 and 2014
3.2 Forecast 2014-2025: Changes Expected?
3.3 Biologic Therapies Forecast 2014-2025 – The Future of Pharma
3.4 Aminosalicylates Forecast 2014-2025: The Work Horse of IBD Market
3.5 Antibiotics Forecast 2014-2025: Scientific Research Important
3.6 Corticosteroids Forecast 2014-2025: Will Uceris Save the Day?
3.7 Immunomodulators Forecast 2014-2025 – Will It Remain Insignificant?
4. Market Prospects for Leading IBD Drugs, 2014-2025
4.1 Humira (AbbVie) – Will It Stand the Wave of Biosimilars?
4.1.1 Humira: Forecast and Analysis, 2014-2025
4.2 Remicade (Janssen Biotech) – Rise and Fall with Humira?
4.2.1 Remicade: Forecast and Analysis, 2014-2025
4.3 Asacol (Actavis) – Will It Regain Its Revenue?
4.3.1 Asacol: Forecast and Analysis, 2014-2025
4.4 Pentasa (Shire) – When Will a Generic Substitute Arrive?
4.4.1 Pentasa: Forecast and Analysis, 2014-2025
4.5 Lialda (Shire) – Will Improved Compliance Increase Revenue?
4.5.1 Lialda: Forecast and Analysis, 2014-2025
4.6 Tysabri (Perrigo) – How Dependable its Prospects?
4.6.1 Tysabri: Forecast and Analysis, 2014-2025
4.7 Xifaxan (Salix Pharmaceuticals) – Growing Stronger?
4.7.1 Xifaxan: Forecast and Analysis, 2014-2025
4.8 Cimzia (UCB) – How Will it Fare Against Biosimilars?
4.8.1 Cimzia: Forecast and Analysis, 2014-2025
4.9 Entocort (AstraZeneca) – A Slow and Steady Decline?
4.9.1 Entocort: Forecast and Analysis, 2014-2025
4.10 Neoral (Novartis) – Immunosuppressant
4.10.1 Neoral: Forecast and Analysis, 2014-2025
4.11 Medrol (Pfizer Inc.) – Another Leading Steroid
4.11.1 Medrol: Forecast and Analysis, 2014-2025
4.12 Canasa (Actavis) – A Slow Decline?
4.12.1 Canasa/Salofalk: Forecast and Analysis, 2014-2025
4.13 Apriso (Salix Pharmaceuticals) – Challenger to Asacol?
4.13.1 Apriso: Forecast and Analysis, 2014-2025
4.14 Azulfidine (Pfizer) – Established Product
4.14.1 Azulfidine: Forecast and Analysis, 2014-2025
4.15 Entyvio (Takeda Pharmaceuticals) – a Future Star Product?
4.15.1 Entyvio: Forecast and Analysis, 2014-2025
4.16 Simponi (Janssen Biotech) – Another Rising Star for the Market?
4.16.1 Simponi: Forecast and Analysis, 2014-2025
4.17 Uceris (Salix) – Corticosteroid for Maintenance Therapy?
4.17.1 Uceris: Forecast and Analysis, 2014-2025
5. Leading National Markets: Sales Outlooks, 2014-2025
5.1 IBD Drugs – Leading National Markets 2013
5.2 The US IBD Drug Market, 2014-2025 – The World Leader
5.3 The Japanese IBD Drug Market, 2014-2025 – Growing Significantly?
5.4 The EU-5 IBD Drug Market, 2014-2025 – Still Growing Together
5.4.1 The German IBD Drug Market, 2014-2025
5.4.2 The French IBD Drug Market, 2014-2025
5.4.3 The UK IBD Drug Market, 2014-2025
5.4.4 The Spanish IBD Drug Market, 2014-2025
5.4.5 The Italian IBD Drug Market, 2014-2025
5.5 IBD Drug Markets in BRIC Countries – How Fast Will They Grow?
5.5.1 The Brazilian IBD Drug Market, 2014-2025
5.5.2 The Russian IBD Drug Market, 2014-2025
5.5.3 The Indian Drug Market, 2014-2025
5.5.4 The Chinese IBD Drug Market, 2014-2025
6. The R&D Pipeline for Inflammatory Bowel Disease, 2014
6.1 Interleukin (IL) Inhibitors – One of the Main Areas of Innovation
6.1.1 CyCol (Sigmoid Pharma)
6.1.2 PF-04236921 (Pfizer)
6.1.3 QAX 576 (Novartis)
6.1.4 TNF Kinoid (Neovacs)
6.1.5 Vidofludimus (4SC) – Suspended
6.1.6 Stelara (Ustekinumab, CNTO 1275, Janssen Biotech)
6.2 Cell-Adhesion Molecule (CAM) Inhibitors – A Promising Avenue
6.2.1 AJG 511 (Ajinomoto Pharmaceutical Co.)
6.2.2 AJM 300 (Ajinomoto Pharmaceuticals)
6.2.3 MEDI 7183/AMG 181 (AstraZeneca & Amgen)
6.2.4 Etrolizumab (Roche)
6.2.5 PF-00547659 (Pfizer)
6.2.6 Alicaforsen (ISIS 2302, Atlantic Healthcare)
6.2.7 MEDI-2070/AMG 139 (AstraZeneca & Amgen)
6.2.8 Entyvio (Vedolizumab, Takeda)
6.3 TNF Inhibitors – a Specific Target
6.3.1 AVX-470 (Avaxia Biologics)
6.3.2 Ozoralizumab (ALX-0061, Ablynx)
6.4 Stem Cell Therapies – Basis for a Cure?
6.4.1 Ovasave (TxCell)
6.4.2 MultiStem (Athersys and Pfizer)
6.4.3 Prochymal (Remestemcel-L, Osiris Therapeutics)
6.4.4 Cx601 (TiGenix
6.5 JAK Inhibitors – New Target Pathway
6.5.1 JNJ-54781532 (Janssen)
6.5.2 Xeljanz, (Tofacitinib, CP-690550, Pfizer)
6.6 Toll-like Receptor Agonists
6.6.1 BL-7040 (BioLineRX)
6.6.2 Kappaproct (InDex Pharmaceuticals)
6.7 Other Classes of Agent
6.7.1 Trichuris suis ova (CNDO-201, Coronado Biosciences)
6.7.2 GLPG0974 (Galapagos)
6.7.3 RPC1063 (Receptos)
6.7.4 SGX203 (Soligenix)
6.7.5 Mongersen (GED-0301, Celgene)
6.7.6 Tetomilast (OPC-6535, Otsuka)
6.7.7 Laquinimod (Active Biotech)
6.7.8 RHB-104 (RedHill Biopharma)
6.7.9 TRK 170 (Toray Industries)
6.8 Biosimilars Candidates – Promising Copies of Leading Biologics?
6.8.1 Possibility of Adalimumab Biosimilars
6.8.2 Possibility of Infliximab Biosimilars
7. Drivers and Restraints in the Inflammatory Bowel Disease Drug Industry and Market, 2015
7.1 SWOT and STEP Analysis of the IBD Market
7.2 What Factors Will Stimulate the IBD Market?
7.2.1 Increasing Disease Incidence
7.2.2 Better Diagnosis – Early Referrals
7.2.3 Delivery Systems
7.2.4 Biological Drugs
7.2.5 Socioeconomic Costs of IBD
7.3 What Factors Will Restrain the Market?
7.3.1 Lack of Understanding of Disease Aetiology
7.3.2 Compliance
7.3.3 Limits of Biologics
7.3.4 The Possible Development of Alternative Treatments
7.3.5 Surgery – Treatment for Recalcitrant IBD
7.3.6 Health Care Cost Containment
8. Leading Companies in the IBD Market, 2014
8.1 The Largest Companies by Revenue
8.1.1 AbbVie – Current Leader and Continually Expanding
8.1.2 Janssen Biotech – Contender for Future Leader of that Market
8.1.3 Actavis – New Comer in the Top Four
8.1.4 Shire Pharmaceuticals – Products and R&D
9. Research Interviews
9.1 Dr Karine Kleinhaus, Divisional Vice President, North America, Pluristem Therapeutics Inc.
9.1.1 On Pluristem Therapeutics Inc.
9.1.2 On PLX Cells
9.1.3 MoA of PLX Cells and What They are Indicated For
9.1.4 Clinical Trial for IBD Indication
9.1.5 Prospects of PLX Cells as a Treatment Option for IBD
9.1.6 On NIH’s Initiation of the Human Placental Project
9.1.7 Cell Therapy and its Place in Biopharma Development
9.1.8 Bridging Clinical Trial and Clinical Outcome
9.1.9 On Pluristem’s Partnerships
9.2 Dr Qamar ul Arfin, Gastroenterologist, Aga Khan University Hospital, Karachi, Pakistan
9.2.1 On Antibiotics in Treating IBD
9.2.2 On the Emergence of Biologic Therapies
9.2.3 On IBD in the Pakistani Context
9.2.4 On Preventative Measures that Can Be Taken
10. Conclusions of the Study
10.1 IBD Market to Expand from 2014 to 2025
10.2 Aminosalicylates and Other Non-Biologic Treatments
10.3 Biological Treatments
10.4 Improvements Needed in IBD Therapy
10.5 Future IBD Treatments: R&D Efforts Look Promising
10.6 The IBD Sector: Looking to the Future with Confidence
【レポート販売概要】
■ タイトル：世界の炎症性腸疾患(IBD)治療薬市場■ 英文：Inflammatory Bowel Diseases (IBD): World Drug Industry and Market 2015-2025
■ 発行日：2014年11月
■ 調査会社：visiongain
■ 商品コード：VGAIN4120208
■ 調査対象地域：グローバル
- 水産養殖のベトナム市場2016-2020About Aquaculture in Vietnam Vietnam is one of the most suitable places for seafood and fish farming because of its long and rich coast line. Infrastructure development, growing consumption of fish, high disposable income of consumers, and export of farmed fish and seafood are some of the key drivers, which enable Vietnam to contribute a significant revenue to the aquaculture industry in APAC. The …
- 天然石の世界市場：種類別（大理石、花崗岩、石灰岩、その他）、用途別（フローリング、メモリアルアーツ、ウォールクラッディング、その他）The global natural stone market was valued at $35,120.1 million in 2018, and is projected to reach $48,068.4 million by 2026, growing at a CAGR of 3.9% from 2019 to 2026. Natural stone refers to mountain–acquired substances. It includes common stones such as sandstone, granite, travertine, limestone, marble, slate, and others. These natural stones are available in a wide range of colors and sizes …
- 世界の提携ロイヤリティー・プログラム市場Based on research covering 235 coalition loyalty programs across a wide range of countries worldwide, Global Coalition Loyalty Programs is a report and related CoalitionBASE™ dataset about the growth in the number and membership of coalition loyalty programs that has occurred globally in recent years and the affinity and partnership marketing opportunities that they offer to a huge range of organi …
- 航空用燃料添加剤の世界市場The report covers the global aviation fuel additives market and divides the market on the basis of type and geography. The market data for these types is given with respect to volume (Kilo Tons) and value (USD Million). The global aviation fuel additives market was valued at $579.5 million in 2014 and is projected to grow at a CAGR of 6.7% from 2014 to 2019. The data mentioned in the report are ba …
- DPaaS（クラウド式データ保護サービス）の世界市場2016-2020About DPaaS DPaaS is a cloud-based service for backup, recovery, or storage of data assets that include data of customers and organizations. It helps organizations to improve the data security for data in transit as well as data at rest. Technavio’s analysts forecast the global data protection as a service (DPaaS) market to grow at a CAGR of 32.61% during the period 2016-2020. [Covered in this rep …
- Mucopolysaccharidosis VI (MPS VI) (マロト‐ラミー症候群)：グローバル臨床試験動向（2014年上半期）Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome) Global Clinical Trials Review, H1, 2014" provides data on the Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome) clinical trial scenario. This report provides elemental information and d …
- オフショア係留システムの世界市場分析：タイプ別（スプレッド、SPM、ダイナミック・ポジショニング、テンドン）、用途別（TLP、半潜水艦、SPAR、FPSO、ドリル船）、足場別、セグメント予測、2014-2025The global offshore mooring systems market is expected to reach USD 1.32 billion by 2025, according to a new report by Grand View Research, Inc. Increasing oil and gas production and exploration from the offshore fields rather than the onshore and the rising development of shale drilling regions for sustainable growth in future is expected to drive the demand for offshore mooring market. Innovatio …
- 穀類・穀物保護用化学薬品の世界市場：除草剤、殺菌剤、殺虫剤About the Grain and Cereal Crop Protection Chemicals Market Soil erosion and land pollution are also reducing the size of arable land per person. This forces farmers to increase the crop yield from limited available land. This, in turn, increases the demand for crop protection chemicals, which helps enhance the yield and quality of crops. Pesticides are used to control pests that feed on crops and …
- マラリア検査の世界市場2015The report presents a detailed analysis of the Malaria diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Malaria definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - …
- セルラーM2M通信およびサービスの世界市場2016-2020About the Cellular M2M Connections and Services Market M2M technology enables the communication of data and information between electronic devices. In cellular M2M connections, code-division multiple access (CDMA), 2G, 3G, and 4G-LTE networks are used to establish connections between electronic devices. Cellular M2M has a broad range of applications in industries such as automotive, healthcare, re …
- 世界のユーバイオティクス（プロバイオティクス、プレバイオティクス、有機酸、精油）市場動向及び予測（～2019）Owing to the ban on use of antibiotics as growth promoters, the rapid rise in living standards, increase in demand for animal protein are driving the demand for better animal feed, which in turn are acting as drivers for the eubiotics market. This report estimates the market value of eubiotic product and its types. In terms of geography, the report is segmented into Asia-Pacific, Europe, North Ame …
- 医薬品受託製造･受託研究の世界市場分析：サービス別（CMO {API /バルク薬物、先端薬物送達完成製剤}}、CRO {腫瘍学、ワクチン、免疫学、心臓学、神経科学}）、セグメント予測、2014-2025The global pharmaceutical contract manufacturing/contract research market is anticipated to reach USD 238.3 billion by 2025, according to a new report by Grand View Research, Inc. Impact on the volume of capacity that is required for production due to of increasing expression levels is anticipated to influence outsourcing industry. Increased cell densities as well as increase in expression of each …
- 汎用テスト機器の世界市場：オシロスコープ、分光分析装置、信号発生器などAbout General Purpose Test Equipment General purpose test equipment includes different testing and measuring equipment like oscilloscopes, spectrum analyzers, signal generators, network analyzers, power meters, logic analyzers, electronic counters, and multimeters. Industries like the Communications and Aerospace and Defence industries use these equipment for testing their design prototype and fin …
- 中国の小売市場2017-2021ABSTRACTAbout Retail Market in China Retail refers to the business process where a business entity sells its products or offers services to an individual. The transaction can occur through different sales channels such as online or brick-and-mortar storefronts. The key characteristic of a sale that qualifies it as a retail transaction is that the end-user is a buyer. Technavio’s analysts forecast …
- オンラインゲームの世界市場：カジュアルゲーム、MMOゲーム、デジタルコンソールゲームAbout the Online Gaming Market The online gaming market is evolving globally. Broadly, there are two major segments for the purchase and use of online games: physical and digital. However, the physical mode of purchase (i.e., via retail) is gradually losing importance. Because of the increasing popularity of the internet and its widespread use and connectivity, developers and publishers have slowl …
